New Targets in Multiple Diseases
David Fiorentino, MD, PhD; Edward Keystone, MD, FRCPC; Philip Mease, MD;
Gary Lichtenstein, MD |
Biologic Therapies and the Allied Health Professional
Kristin Englund, MD; Elizabeth Kirchner, NP; William Wilke, MD |
Inflammatory Bowel Diseases and Biologic Agents
Jean-Paul Achkar, MD; Bret Lashner, MD; Lloyd Mayer, MD |
Liver Disease
Ariel E. Feldstein, MD; Robert O'Shea, MD, MSCE; Nizar N. Zein, MD
Mt. Sinai School of Medicine |
Rheumatoid Arthritis, Juvenile Arthritis, Ankylosing Spondylitis
Ferdinand Breedveld, MD; Edward Keystone, MD, FRCPC; Philip Mease, MD;
Nora Singer, MD |
Current Concepts in Psoriasis and Psoriatic Arthritis
Elaine Husni, MD, MPH; Philip Mease, MD; Abrar Qureshi, MD, MPH |
State of the Art: Biologic Toxicity Epidemiology, Clinical Spectrum,
Diagnosis, and Prevention
Marc D. Cohen, MD; Jack Cush, MD; Jerrold J. Ellner, MD; Thomas File, MD;
Richard Rudick, MD |
Advances in Mucosal Immunology
Lloyd Mayer, MD
Mt. Sinai School of Medicine |
Pros and Cons of the Quality Movement
Neal Birnbaum, MD
University of California, San Francisco |
Biologic Therapeutic Classes and Agents: Shared Mechanisms of Action Across Disease States
Ferdinand Breedveld, MD - Leiden University Medical Center;
Chad Deal, MD - Cleveland Clinic;
E. William St. Clair, MD - Duke University Medical Center;
Vibeke Strand, MD - Stanford University |
Immunologic Mechanisms in Bone Destruction: A New Therapeutic Target
Christopher T. Ritchlin, MD -
University of Rochester Medical Center |
|
